Hi-Clearance Inc. (TPEX:1788)

Taiwan · Delayed Price · Currency is TWD

131.00

0.00 (0.00%)

Jun 17, 2026, 1:30 PM CST

-9.03% (1Y)

Market Cap	5.83B -8.4%
Revenue (ttm)	4.37B +5.2%
Net Income	388.24M +11.5%
EPS	8.71 +11.5%
Shares Out	44.52M
PE Ratio	15.04
Forward PE	n/a
Dividend	7.00 (5.34%)
Ex-Dividend Date	Jun 16, 2026

Volume	72,586
Open	131.00
Previous Close	131.00
Day's Range	130.00 - 131.00
52-Week Range	129.00 - 145.00
Beta	0.07
Analysts	Hold
Price Target	90.00 (-31.3%)
Earnings Date	Aug 10, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysi... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1989

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 1788

Full Company Profile

Financial Performance

In 2025, Hi-Clearance's revenue was 4.28 billion, an increase of 5.04% compared to the previous year's 4.07 billion. Earnings were 368.51 million, an increase of 2.45%.

Financial Statements